- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
STRATEC Biomedical AG (SBSG)
The STRATEC Biomedical share price today is 17.600, view ETR SBSG stock exchange data. Track the latest STRATEC Biomedical share price with real-time updates on SBSG stock performance including market cap, day range, 52-week range and dividend yield. Access SBSG charts, earnings dates and analyst estimates to support your investment decisions.
17.600
-0.020(-0.11%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.300
17.800
52 wk Range
16.360
33.100
Earnings results expected in 9 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.30017.800
52 wk Range
16.36033.100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.41%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.41%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SBSG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
28.200
Upside
+60.23%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has maintained dividend payments for 23 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 28.200
(+60.23% Upside)
Earnings
Latest Release
28-04-2026
EPS / Forecast
-0.36 / --
Revenue / Forecast
75.3M / --
Compare SBSG to Peers and Sector
Metrics to compare | SBSG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSBSGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −884.1x | 19.2x | −0.5x | |
PEG Ratio | 8.71 | 0.03 | 0.00 | |
Price/Book | 0.9x | 1.7x | 2.6x | |
Price / LTM Sales | 0.9x | 1.7x | 3.2x | |
Upside (Analyst Target) | 64.8% | 41.1% | 47.8% | |
Fair Value Upside | Unlock | 5.8% | 6.7% | Unlock |
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the STRATEC Biomedical (SBSG) Share Price Today?
The STRATEC Biomedical share price today is 17.600.
What is the current STRATEC Biomedical (SBSG) share price and day range?
As of 02-05-2026, the STRATEC Biomedical share price is 17.600, with a previous close of 17.620. The share price has ranged from 17.300 to 17.800 today, while the 52-week range spans from 16.360 to 33.100.
What Is the STRATEC Biomedical Market Cap?
As of today, STRATEC Biomedical market cap is 213.940M.
Does STRATEC Biomedical Pay Dividends? What's The Current Dividend Yield?
The STRATEC Biomedical dividend yield is 3.41%.
What Is the STRATEC Biomedical (SBSG) Share Price Target?
The average 12-month share price target for STRATEC Biomedical is 28.200, with a high estimate of 37 and a low estimate of 20. 4 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +60.23% Upside potential.
What Is STRATEC Biomedical's Earnings Per Share (TTM)?
The STRATEC Biomedical EPS (TTM) is -0.020.
When Is the Next STRATEC Biomedical Earnings Date?
STRATEC Biomedical will release its next earnings report on 11-05-2026.
From a Technical Analysis Perspective, Is SBSG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does STRATEC Biomedical Trade On?
STRATEC Biomedical is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for STRATEC Biomedical?
The stock symbol for STRATEC Biomedical is "SBSG."
How Many Times Has STRATEC Biomedical Stock Split?
STRATEC Biomedical has split 1 times.
How Many Employees Does STRATEC Biomedical Have?
STRATEC Biomedical has 1420 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.